Based on the measurements of operating efficiency obtained from InspireMD's historical financial statements, InspireMD may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, InspireMD's Total Current Assets are relatively stable compared to the past year. As of 06/22/2025, Short and Long Term Debt Total is likely to grow to about 2.9 M, though Net Debt is likely to grow to (15.7 M). Key indicators impacting InspireMD's financial strength include:
The essential information of the day-to-day investment outlook for InspireMD includes many different criteria found on its balance sheet. An individual investor should monitor InspireMD's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in InspireMD.
InspireMD competes with Bone Biologics, Tivic Health, Bluejay Diagnostics, Vivos Therapeutics, and Rapid Micro. InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel. Inspiremd operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 50 people.
The reason investors look at the income statement is to determine what InspireMD's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining InspireMD's current stock value. Our valuation model uses many indicators to compare InspireMD value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across InspireMD competition to find correlations between indicators driving InspireMD's intrinsic value. More Info.
InspireMD is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, InspireMD's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value InspireMD by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
InspireMD Systematic Risk
InspireMD's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. InspireMD volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on InspireMD correlated with the market. If Beta is less than 0 InspireMD generally moves in the opposite direction as compared to the market. If InspireMD Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one InspireMD is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of InspireMD is generally in the same direction as the market. If Beta > 1 InspireMD moves generally in the same direction as, but more than the movement of the benchmark.
InspireMD Thematic Clasifications
InspireMD is part of Medical Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in InspireMD Stock are looking for potential investment opportunities by analyzing not only static indicators but also various InspireMD's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of InspireMD growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of InspireMD help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of InspireMD. We use our internally-developed statistical techniques to arrive at the intrinsic value of InspireMD based on widely used predictive technical indicators. In general, we focus on analyzing InspireMD Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build InspireMD's daily price indicators and compare them against related drivers.
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.